Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.
about
Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infectionsTargeting interleukin-1 in heart diseaseThe puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Effects of Acute Exercise on Circulating Soluble Form of the Urokinase Receptor in Patients With Major Depressive Disorder.Inflammation, the acute phase response and atherosclerosis.Left ventricular function and C-reactive protein levels in acute myocardial infarctionSerum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarctionC-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.Inducible and tissue-specific expression of human C-reactive protein in transgenic mice.Reliability and feasibility of a near patient test for C-reactive protein in primary care.Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.In vivo studies of serum C-reactive protein turnover in rabbitsC-reactive protein and cardiovascular disease: new insights from an old molecule.C reactive protein in the evaluation of febrile illness.Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease.Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection.Systemic inflammation (C-reactive protein) in type 2 diabetic patients is associated with ambient air pollution in Pune City, India.Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulusSerum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.Acute phase reactants as novel predictors of cardiovascular disease.Serum amyloid A concentrations during the course of acute ischaemic heart disease.C-reactive protein at the interface between innate immunity and inflammation.Role of C-reactive protein in cerebrovascular disease: a critical review.A Comparative Study of the C-Reactive Protein and the ST-Score (ECG) as Prognostic Indicators in Acute Myocardial Infarction in a Rural Resource-Constrained Hospital Setting in Central India: A Cross-Sectional Study.A comparison of the acute-phase response in middle aged and elderly patientsSerum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.Sensitive and rapid measurement of C-reactive protein (CRP) by lipid agglutination.Rat serum amyloid P component. Analysis of cDNA sequence and gene expression.C reactive protein concentrations during long distance runningStudies of translatable mRNA for rabbit C-reactive protein.Value of C-reactive protein in detecting complications after open-heart surgery in children.Rapid determination of C-reactive protein by enzyme immunoassay using two monoclonal antibodies.Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2.C-reactive protein levels for early detection of early postoperative complications after proximal femoral fracture surgery.Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats.Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator.Evaluation of possible tissue damage in patients undergoing extracorporeal shock wave lithotripsy employing C-reactive protein.
P2860
Q24653928-D3B61C7B-1F3E-4CF4-BF56-75A1F4E86531Q27009347-1C89369F-686D-47AC-AA00-6A5DAA4FAACFQ33351796-5755A7FF-778D-4212-BD2B-C8A0ECC8177CQ33580655-BF1D4A84-5EF3-4234-A5BA-281AB4081760Q33694694-BBCA7702-C847-4DF5-99C2-473E9C5FF107Q33761764-4769103F-7D00-4BE9-8F67-21A16F29B820Q33839659-64A9806C-A29D-45DF-9841-B527221FBCA4Q33883883-681B6EBE-6258-4609-9D6A-A6EE2BFA81E5Q33930080-BB83F8A5-8858-428F-B6CF-998066FBE4A7Q34054942-4A85A3D0-ED0C-4616-AA29-22A243C6EA49Q34056876-6A017A65-9AA6-42BE-8FC7-9A629313D8BFQ34767602-4F824F81-CD1E-4555-A2C9-7617E8899412Q35204298-10EDC882-744C-4E32-86D0-CA57BBD7E3C5Q35562701-6DA4A162-BB57-48EB-B530-0C5916F79A01Q35602345-00DDB4F3-A1D3-44D9-89E1-8DB5BCF6CF68Q35605333-7EACF79B-A660-4F50-ADFF-71EDC4F535F4Q35829209-48FE94A0-FC36-4BB6-A6AB-1C21368B02B1Q36341777-9D34D0BB-5104-466C-8EE6-26DD378A472DQ36590832-C4E28473-AD3A-4C00-8AF5-5DA434C2708BQ36629446-689F7201-34AF-43E5-A427-70C7999B5C33Q36762903-ED9103A1-43FA-4F44-96EA-4B9D12F9B4FDQ37042783-36E55A90-CA67-40AC-B68D-7508E9AADAFFQ37156874-5B932C4C-6C48-4B54-8C54-C89D4E35B29EQ37208763-1220F94D-B6A0-4652-8804-54A517DE2977Q37754545-15F1CDD6-B44A-45E6-AE81-62DD6366AF90Q37959060-1B2B7603-F0E0-48FC-95EF-FA20AF7C4192Q38564613-636ED5FD-99C4-4F8C-9103-5ADABE3CC1F7Q39192746-3CED3260-6946-4D5E-9A09-67C008D1DAE0Q40576505-1494C5ED-DE0F-4D44-BC4E-AB65131DABB4Q41808516-0459A39D-787D-4AFD-9A34-E122B02AE14AQ41866583-87D78F20-40B9-4C9B-8F70-C093253AC5B7Q41870122-89F838D6-9484-485A-A101-FA4584956CEFQ42100832-FC4D0C69-A1DF-4A34-B97C-68F82F44DA55Q43867563-41761CBD-328F-4DD0-A482-DC6325FC3781Q43953497-2C08A0AC-B0DF-44B9-9FB7-08203F0F54B6Q46769768-D29CA521-1AB3-4498-A87E-57529AD2A0FDQ47375278-DA159AA7-E4E3-4C0B-9818-0315DB750A4FQ47400800-4633BFBF-4A10-496D-9202-2F47097F7514Q47437590-E4144E26-65EF-4370-B9F8-7A588DDEA6CDQ53771707-59B38BF7-54D2-4EA5-8347-B3C2FB7B3799
P2860
Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.
description
1978 nî lūn-bûn
@nan
1978 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Control of the acute phase res ...... r acute myocardial infarction.
@ast
Control of the acute phase res ...... r acute myocardial infarction.
@en
Control of the acute phase res ...... r acute myocardial infarction.
@nl
type
label
Control of the acute phase res ...... r acute myocardial infarction.
@ast
Control of the acute phase res ...... r acute myocardial infarction.
@en
Control of the acute phase res ...... r acute myocardial infarction.
@nl
prefLabel
Control of the acute phase res ...... r acute myocardial infarction.
@ast
Control of the acute phase res ...... r acute myocardial infarction.
@en
Control of the acute phase res ...... r acute myocardial infarction.
@nl
P2093
P2860
P356
P1476
Control of the acute phase res ...... r acute myocardial infarction.
@en
P2093
P2860
P304
P356
10.1172/JCI108932
P407
P577
1978-02-01T00:00:00Z